- Home
- XCUR vs UG Comparison
XCUR vs UG Comparison
Compare XCUR & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- UG
- Stock Information
- Founded
- XCUR 2011
- UG 1942
- Country
- XCUR United States
- UG United States
- Employees
- XCUR N/A
- UG N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- XCUR Health Care
- UG Consumer Discretionary
- Exchange
- XCUR Nasdaq
- UG Nasdaq
- Market Cap
- XCUR 32.4M
- UG 36.1M
- IPO Year
- XCUR N/A
- UG N/A
- Fundamental
- Price
- XCUR $3.55
- UG $7.99
- Analyst Decision
- XCUR
- UG
- Analyst Count
- XCUR 0
- UG 0
- Target Price
- XCUR N/A
- UG N/A
- AVG Volume (30 Days)
- XCUR 28.2K
- UG 4.6K
- Earning Date
- XCUR 11-13-2025
- UG 11-07-2025
- Dividend Yield
- XCUR N/A
- UG 8.76%
- EPS Growth
- XCUR N/A
- UG N/A
- EPS
- XCUR N/A
- UG 0.56
- Revenue
- XCUR N/A
- UG $10,856,174.00
- Revenue This Year
- XCUR N/A
- UG N/A
- Revenue Next Year
- XCUR N/A
- UG N/A
- P/E Ratio
- XCUR N/A
- UG $14.70
- Revenue Growth
- XCUR N/A
- UG N/A
- 52 Week Low
- XCUR $2.07
- UG $7.73
- 52 Week High
- XCUR $36.00
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- XCUR 23.74
- UG 44.56
- Support Level
- XCUR $3.10
- UG $7.84
- Resistance Level
- XCUR $4.21
- UG $8.45
- Average True Range (ATR)
- XCUR 0.37
- UG 0.27
- MACD
- XCUR -0.07
- UG -0.04
- Stochastic Oscillator
- XCUR 16.27
- UG 19.39
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.